Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-01

Clinical Trial Update: Lamotrigine Bioequivalence [Phase 4]

View source ↗

Summary

Phase 4 bioequivalence trial of lamotrigine completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2020-12-01